Clinical trial
Memantine and Comprehensive, Individualized Management of Alzheimer's Disease…
NCT00120874 · NYU Langone Health, Other · Completed
Key facts
| NCT number | NCT00120874 |
|---|---|
| Title | Memantine and Comprehensive, Individualized Management of Alzheimer's Disease and Caregiver Training |
| Official title | Memantine and Comprehensive, Individualized, Patient Centered Management of Alzheimer's Disease: A Randomized Controlled Trial |
| Lead sponsor | NYU Langone Health, Other |
| Collaborators | Forest Laboratories Industry Fisher Center for Alzheimer's Research Foundation |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Alzheimer's Disease |
| Intervention type | Behavioral, Drug |
| Interventions | Individualized management of AD including caregiver training, Memantine |
| Enrollment | 20 |
| Start date | Aug 1, 2006 |
| Primary completion | Nov 1, 2011 |
| Completion | Nov 1, 2011 |
| First posted | Jul 19, 2005 |
| Last update posted | Oct 25, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: